Rimegepant

Overview

Rimegepant is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2178422).

API suppliers (1)

Suppliers of Rimegepant backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Porton Pharma Solutions Ltd.China1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Rimegepant expires 25 Mar 2039. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

[(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl] 4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate

Canonical SMILES

C1C[C@H](C2=C(C=CC=N2)[C@H]([C@@H]1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6

InChIKey

KRNAOFGYEFKHPB-ANJVHQHFSA-N